I'm sure most would have read the ANN where it stated that 1/4 dose sales will no longer be published.
We have the fluffy story about concentrating on the 2020 vision, but there is no cost to SRX in publishing this data, so what are the views out there as to why this reduction in measurable data?
- Forums
- ASX - By Stock
- SRX
- No more 1/4 dose sales
No more 1/4 dose sales
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SRX (ASX) to my watchlist
(20min delay)
|
|||||
Last
18.0¢ |
Change
0.003(1.41%) |
Mkt cap ! $76.40M |
Open | High | Low | Value | Volume |
18.0¢ | 18.3¢ | 18.0¢ | $4.879M | 27.11M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 38609948 | 18.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
18.5¢ | 1070000 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 37709948 | 0.180 |
8 | 4711200 | 0.175 |
1 | 164705 | 0.170 |
1 | 18187 | 0.165 |
1 | 2577 | 0.097 |
Price($) | Vol. | No. |
---|---|---|
0.185 | 1070000 | 4 |
0.190 | 285669 | 5 |
0.195 | 50478 | 3 |
0.200 | 352416 | 5 |
0.205 | 2900 | 2 |
Last trade - 16.10pm 10/09/2024 (20 minute delay) ? |
Featured News
SRX (ASX) Chart |